全球快速医疗诊断试剂盒市场规模、份额和成长分析:按产品、最终用途- 产业预测(2023-2030)
市场调查报告书
商品编码
1360428

全球快速医疗诊断试剂盒市场规模、份额和成长分析:按产品、最终用途- 产业预测(2023-2030)

Global Rapid Medical Diagnostic Kits Market Size, Share, Growth Analysis, By Product(Over the Counter (OTC) Kits, and Professional Kits), By End use(Hospitals & Clinics, Home Care) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球快速医疗诊断试剂盒市场规模预计将从2022年的161.3亿美元增至2030年的210.8亿美元,在预测期内(2023-2030年)年复合成长率为3.4%。

市场成长的主要促进因素包括对即时诊断的需求不断增长、感染疾病的爆发以及对即时医疗见解的需求。由于技术进步和医疗意识的提高,预计市场将呈现持续成长。

促进因素

COVID-19、流感、爱滋病毒和性行为感染等传染病的发生率迅速增加,增加了对快速医疗诊断试剂盒的需求。

抑制因素

严格的法规标准

快速医疗诊断试剂盒需要满足严格的法规标准,以确保其安全性、准确性和可靠性。核准并维持对必要法规标准的遵守需要时间和金钱,这对市场进入造成了障碍,特别是对于较小的製造商。

市场趋势

市场专注于开发携带式、用户友好的快速诊断工具。这些设备有助于测试,特别是在资源有限和偏远地区。使用者友善的介面和清晰的说明提高了这些工具对医疗保健专业人员和最终用户的可近性和可用性。

本报告研究分析了全球快速医疗诊断试剂盒市场,提供市场动态与预测、細項分析、公司简介等。

目录

执行摘要

调查方法

母市场分析

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功要素
  • 竞争程度

市场动态及预测

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
  • 法规形势
  • 波特的分析
  • 对未来中断的特殊考察

全球快速医疗诊断试剂盒市场:按产品

  • 市场概况
  • 非处方药套件
  • 商务用套件

全球快速医疗诊断试剂盒市场:依最终用途

  • 市场概况
  • 医院/诊所
  • 居家照护
  • 诊断实验室

全球快速医疗诊断试剂盒市场规模(按地区)

  • 市场概况
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 其他拉丁美洲
  • 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争形势

  • 前5名企业对比
  • 主要企业市场定位(2021年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2021年)

主要企业简介

  • Abbott Laboratories - USA
  • Becton, Dickinson and Company (BD) - USA
  • BioMerieux - France
  • Cepheid (A Danaher Company) - USA
  • Chembio Diagnostic Systems, Inc. - USA
  • CTK Biotech - USA
  • Diasorin SpA - Italy
  • F. Hoffmann-La Roche Ltd. - Switzerland
  • Hologic, Inc. - USA
  • Luminex Corporation - USA
  • Meridian Bioscience, Inc. - USA
  • OraSure Technologies, Inc. - USA
  • PerkinElmer, Inc. - USA
  • QIAGEN NV - Netherlands
  • Siemens Healthineers AG - Germany
  • Sysmex Corporation - Japan
  • Thermo Fisher Scientific Inc. - USA
  • Trinity Biotech - Ireland
  • Quidel Corporation - USA
  • Zybio Inc. - China
简介目录
Product Code: SQMIG35A2413

Market Insights

Global Rapid Medical Diagnostic Kits Market size was valued at USD 15.6 Billion in 2021 and is poised to grow from USD 16.13 Billion in 2022 to USD 21.08 Billion by 2030, at a CAGR of 3.4% during the forecast period (2023-2030).

The Global Rapid Medical Diagnostic Kits Market comprises innovative tools that swiftly detect various medical conditions. These kits offer quick and accurate results, enhancing patient care and disease management. Key factors driving market growth include the rising demand for point-of-care diagnostics, infectious disease outbreaks, and the need for immediate medical insights. With expanding technological advancements and increasing healthcare awareness, the market for rapid medical diagnostic kits is projected to experience sustained growth.

Top-down and bottom-up approaches were used to estimate and validate the size of rapid medical diagnostic kits and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global rapid medical diagnostic kits market is segmented on the basis of product, end use, and region. By product, the market is segmented into Over the Counter (OTC) Kits and Professional Kits. By end use, the market is segmented into Hospitals & Clinics, Home Care, and Diagnostic Laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers

The escalating occurrence of contagious ailments like COVID-19, flu, HIV, and sexually transmitted infections has generated an amplified need for swift medical diagnostic kits. Such kits allow prompt and precise pathogen identification, aiding in the early detection and control of diseases.

Restraints

Demanding Regulatory Standards:

Rapid medical diagnostic kits are obligated to meet rigorous regulatory criteria to guarantee their safety, precision, and dependability. Acquiring necessary regulatory endorsements and upholding adherence can consume time and financial resources, posing an impediment to market access, particularly for smaller producers.

Market Trends

Emphasis is shifting towards the creation of portable and user-friendly rapid diagnostic tools in the Global Rapid Medical Diagnostic Kits Market. These devices facilitate on-the-spot testing, especially in areas with limited resources and remote locations. The incorporation of user-friendly interfaces and clear instructions improves the accessibility and usability of these tools for both medical practitioners and end-users.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Rapid Medical Diagnostic Kits Market by Product
  • Market Overview
  • Over the Counter (OTC) Kits
  • and Professional Kits
  • Global Rapid Medical Diagnostic Kits Market by End use
  • Market Overview
  • Hospitals & Clinics
  • Home Care
  • and Diagnostic Laboratories
  • Global Rapid Medical Diagnostic Kits Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Abbott Laboratories - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Becton, Dickinson and Company (BD) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • BioMerieux - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Cepheid (A Danaher Company) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Chembio Diagnostic Systems, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • CTK Biotech - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Diasorin S.p.A. - Italy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • F. Hoffmann-La Roche Ltd. - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Hologic, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Luminex Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Meridian Bioscience, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • OraSure Technologies, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • PerkinElmer, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • QIAGEN N.V. - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Siemens Healthineers AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Sysmex Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Thermo Fisher Scientific Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Trinity Biotech - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Quidel Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Zybio Inc. - China
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments